CAS No. 1621862-70-1
Batch:
Purity:99.04
Chemical Structure
Check the
Lirametostat (CPI-1205)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide | |
|---|---|---|
| CAS Number | 1621862-70-1 | |
| Molecular Formula |
C27H33F3N4O3 |
|
| Molecular Weight (MW) | 518.57 | |
| SMILES | CC1=CC(=C(C(=O)N1)CNC(=O)C2=C(N(C3=CC=CC=C32)C(C)C4CCN(CC4)CC(F)(F)F)C)OC | |
| InChIKey | HPODOLXTMDHLLC-QGZVFWFLSA-N |
Lirametostat (CPI-1205) is an orally available selective inhibitor of EZH2 (IC50 = 2 nM) and EZH1 (IC50 = 52 nM). By targeting EZH2, the catalytic subunit of polycomb repressive complex 2 (PRC2), it selectively reduces cellular histone H3 lysine 27 trimethylation (H3K27me3) levels. This inhibition alters chromatin structure, derepresses silenced tumor suppressor genes, and impairs cancer cell proliferation and tumor growth in PRC2-dependent malignancies. [1]
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
100 mg/mL
(192.83 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 100 mg/mL |
| Water | Insoluble |
| DMSO |
100 mg/mL
(192.83 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Ethanol | 100 mg/mL |
| Water | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- Lirametostat (CPI-1205) Clinical Trials
- Lirametostat (CPI-1205) Solubility in DMSO
- Lirametostat (CPI-1205) Stock Solution
- Lirametostat (CPI-1205) Storage
- Lirametostat (CPI-1205) Stability
- Lirametostat (CPI-1205) Molecular Weight
- Lirametostat (CPI-1205) SMILES
- Lirametostat (CPI-1205) Chemical Structure (2D and 3D)
- Lirametostat (CPI-1205) SDS|MSDS
Note: Technical data last updated: Sep 1, 2026.